Icon Wealth Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$438K Sell
13,201
-5,997
-31% -$212K 0.05% 185
2023
Q2
$704K Buy
19,198
+219
+1% +$8.52K 0.07% 161
2023
Q1
$774K Buy
+18,979
New +$820K 0.08% 161
2022
Q2
$873K Sell
16,651
-3,082
-16% -$157K 0.1% 148
2022
Q1
$1.02M Buy
19,733
+4,320
+28% +$224K 0.1% 148
2021
Q4
$910K Sell
15,413
-5,308
-26% -$263K 0.09% 157
2021
Q3
$891K Sell
20,721
-6,482
-24% -$287K 0.09% 169
2021
Q2
$1.06M Buy
27,203
+2,773
+11% +$108K 0.11% 150
2021
Q1
$885K Buy
24,430
+11,560
+90% +$410K 0.11% 149
2020
Q4
$474K Sell
12,870
-794
-6% -$29.1K 0.07% 181
2020
Q3
$476K Sell
13,664
-18,092
-57% -$634K 0.09% 149
2020
Q2
$985K Buy
31,756
+16,335
+106% +$555K 0.24% 82
2020
Q1
$478K Buy
15,421
+2,124
+16% +$72.4K 0.19% 63
2019
Q4
$494K Buy
13,297
+1,521
+13% +$54.2K 0.16% 71
2019
Q3
$401K Buy
11,776
+257
+2% +$9.35K 0.14% 80
2019
Q2
$473K Buy
11,519
+678
+6% +$26.9K 0.17% 72
2019
Q1
$437K Sell
10,841
-748
-6% -$30K 0.16% 76
2018
Q4
$480K Sell
11,589
-4,342
-27% -$180K 0.23% 67
2018
Q3
$666K Buy
15,931
+2,307
+17% +$88.8K 0.28% 58
2018
Q2
$469K Sell
13,624
-2,211
-14% -$75.6K 0.2% 82
2018
Q1
$533K Sell
15,835
-4,537
-22% -$156K 0.29% 78
2017
Q4
$700K Buy
+20,372
New +$695K 0.35% 65

Other funds holding PFE

Icon Wealth Partners's PFE Position: Q3 2023 in Review

Icon Wealth Partners reduced its Pfizer (PFE) stake by 31% in Q3 2023, selling an estimated $212K and leaving 13,201 shares worth $438K. The position accounts for 0.05% of the portfolio, ranked #185.

Icon Wealth Partners first reported a position in PFE in Q4 2017 and has held it in 22 quarters since. The position peaked at $1.06M in Q2 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

  • Icon Wealth Partners held 13,201 shares of Pfizer worth $438K as of Q3 2023.
  • Icon Wealth Partners sold 5,997 Pfizer shares in Q3 2023, an estimated $212K.
  • Pfizer made up 0.05% of Icon Wealth Partners's portfolio in Q3 2023, its #185 holding.
  • Icon Wealth Partners first reported a position in Pfizer in Q4 2017 and has held it in 22 quarters since.
  • Icon Wealth Partners's Pfizer position peaked at $1.06M in Q2 2021.
  • 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Icon Wealth Partners's 13F filing for Q3 2023, filed 14 Nov 2023.